Filters — stack with AND. Click Reset to clear.
- Tissue / Subtype — DepMap OncotreeLineage and primary disease subtype.
- Sex — annotation and expression are two independent axes (see below).
- Hotspot filter — only show cell lines mutated in this gene at a hotspot position.
- Fusion filter — the dropdown lists clinically relevant fusion pairs first (★ BCR-ABL1, ★ EWSR1-FLI1, …) followed by the gene-based long tail. Selecting a pair filters to the curated set; selecting a gene returns any line with any fusion involving that gene.
- Oncoprint — mutation heatmap across filtered cell lines.
Hotspot variants — when DepMap's inferred-subtype pipeline calls a specific codon (KRAS p.G12D, BRAF p.V600E, EGFR p.L858R, JAK2 p.V617F, EGFR exon-19 del), the variant is appended in green next to the gene name in the Hotspot Mutations list. Generic group calls like KRAS p.G12 (any G12 not specifically D or C) are also shown when no specific call is available. Source: OmicsInferredMolecularSubtypes.csv.
Functional loss — integrated tumor-suppressor inactivation calls (RB1, TP53, PTEN, NF1, CDKN2A, VHL, MTAP, APC) shown as red-bordered chips in the detail panel. A gene is "lost" if any of: WGS-based relative CN < 0.3, likely-LoF mutation with AF > 0.5, or expression < 0.1 log-TPM. This catches deletion-driven losses that the damaging-mutation matrix alone misses — e.g. CDKN2A homozygous deletion in 445 lines (~37% of the panel), most of which look mutation-clean. Source: OmicsInferredMolecularSubtypes.csv.
MSI badge — small red MSI chip next to the cell-line ID when MSIsensor2 score ≥ 20 (DepMap's threshold for microsatellite instability).
Genome signatures (small row near the top of the detail panel) — Ploidy (PureCN avg chromosome dosage), WGD (whole-genome doubling, shown in red when positive — ~58% of the panel), Aneuploidy (Ben-David 2021 score, 0–39), CIN (chromosomal instability). These shape interpretation when comparing gene effect across cell lines — WGD-positive lines are systematically different. Source: OmicsGlobalSignatures.csv.
Each new section in the detail panel has an inline ? with a hover tooltip recapping the key explanation, so you don't need to come back to this modal to remember what a tier or column means.
Clinically relevant fusions — shown as green/amber/red chips in the cell line detail panel.
- Curated list of ~50 well-validated driver fusions (BCR-ABL1, EWSR1-FLI1, EML4-ALK, PML-RARA, TMPRSS2-ERG, …) sourced from COSMIC fusion gene census.
- Each call is validated per cell line on three orthogonal signals: lineage match, partner expression z-score vs lineage-matched negatives, and partner dependency (CRISPR gene effect) z-score. Only the signals the curator marked as informative for that fusion are scored — e.g. BCR-ABL1 doesn't elevate ABL1 mRNA, so expression isn't checked and the call rests on the strong ABL1 dependency.
- high — both informative signals support the call (or one strong + the other directionally supportive).
- med — partial orthogonal support, or curated + lineage match without orthogonal validation.
- low — neither signal supports and lineage doesn't match the canonical disease — suspect, often artifact.
- ⚠ atypical — the cell line's tissue isn't the canonical context for this fusion (e.g. EML4-ALK in a Bowel line). Lineage is a modifier, not a gate: when orthogonal evidence is strong the call is kept and flagged, not hidden — could be a misclassified line or a genuine rare event worth investigating.
- Source: Arriba-annotated fusion calls from
OmicsFusionFilteredSupplementary.csv, filtered to confidence=high with read-through transcripts dropped.
Sex — two independent axes:
- Sex (annotation) — from DepMap's Model table (patient-reported). Values: Male, Female, Unknown.
- Sex (expression) — computed from Y-chromosome markers (RPS4Y1, DDX3Y, EIF1AY, KDM5D, UTY, USP9Y) and XIST expression. Rules: Y-mean > 1.0 log-TPM → male; XIST > 1.0 with Y low → female; otherwise unknown. Validated on DepMap-labeled cells: ~3% false-positive on males, ~0.14% on females.
When expression is “Unknown”:
- Annotation Male → “Unknown (likely Y-chromosome loss)” — Y loss is common in cancer, esp. older male patients and advanced tumors.
- Annotation Female → “Unknown (likely XIST silencing)” — XIST silencing is documented in breast and other cancers.
Sex symbols in the list
- ♂ blue, upright: Male by annotation.
- ♀ pink, upright: Female by annotation.
- ♂ blue, italic: Male by expression only (annotation unknown).
- ♀ pink, italic: Female by expression only (annotation unknown).
- ? gray: Unknown in both axes.
Sort options
- Name — alphabetical.
- Tissue + Subtype — alphabetical by tissue, then subtype within each tissue.
- Hotspot muts — number of hotspot-mutated genes per cell line (descending by default).
- Damaging muts — number of genes with damaging (deleterious / loss-of-function) somatic mutations per cell line (descending). Source: DepMap
OmicsSomaticMutationsMatrixDamaging.
- Fusions — number of distinct fusion/translocation partner genes per cell line (descending).
- GE for gene(s) — enter one or more genes; cells sorted by CRISPR gene effect (Chronos score). For multiple genes the mean across the panel is used — rank cells by combined essentiality.
- Expression of gene(s) — enter one or more genes; cells sorted by log₂(TPM+1) expression (descending by default, so highest-expressing cells surface first). Multiple genes are averaged, so a panel like
CDKN2A, RB1 or ASCL1, NEUROD1, CHGA, SYP finds cells with the strongest combined signature.
Gene-sort input: comma, semicolon, newline or whitespace can separate multiple symbols.
Data source: DepMap 25Q3. All filters and sorts use the data currently loaded in the browser; changing tissue / subtype filters narrows the visible set that subsequent sorts operate on.